Login

ISCCPCON 2024

13–14 Apr 2024
AIIMS Raipur
Asia/Kolkata timezone

Contact

Contribution List

102 out of 102 displayed
Export to PDF
  1. 103. Pretest
    13/04/2024, 09:00
  2. 91. Workshop 2 - Pre-test
    13/04/2024, 09:00
  3. 80. Workshop 3- Introduction
    Dr Nilaj Bagde (AIIMS Raipur)
    13/04/2024, 09:00
  4. 92. Workshop 2 - Introduction
    Dr Asha Jain
    13/04/2024, 09:05
  5. 104. Introduction
    Dr Pushpawati Thakur PUSHPA
    13/04/2024, 09:10
  6. 81. Normal Pap Smear and Evolution of The Betheseda System of reporting
    Dr Rahul Satarkar (AIIMS Raipur)
    13/04/2024, 09:10
    Lecture
    Workshop 3
  7. 93. Tissue basic of colposcopy of vulva &vagina
    Dr Sushil Kumar Giri
    13/04/2024, 09:15
  8. 107. Workshop 1 – Nomenclature & Documentation & Mounting of Specimen - with Video Demonstration
    Dr Geethanjali Amin
    13/04/2024, 09:20
  9. 82. Pap Smear - Squamous Cell Abnormality
    Dr Nighat Hussain (AIIMS Raipur)
    13/04/2024, 09:25
  10. 94. Normal/ Abnormal Vaginal findings & Tips & Tricks for effective Colposcopy in vulva &vagina
    Dr Priya Ganeshkumar
    13/04/2024, 09:35
  11. 83. Pap Smear - Glandular cell abnormality
    Dr Yashita Gupta (AIIMS Raipur)
    13/04/2024, 09:40
  12. 106. Tips & Tricks For effective colposcopy - with Video Demonstration
    Dr Gauri Gandhi
    13/04/2024, 09:45
  13. 84. Technique of Cervical Sampling and Self Sampling
    Dr Mamta Dagar
    13/04/2024, 09:55
  14. 95. Nomenclature & Documentation of Colposcopy in vulva &vagina.
    Dr Pratibha Singh (AIIMS Jodhpur)
    13/04/2024, 10:05
  15. 85. Role of HPV in Cervical Screening
    Dr Bindiya Gupta
    13/04/2024, 10:10
  16. 105. Tissue basis of colposcopy of cervix
    Dr Nisha Singh
    13/04/2024, 10:10
  17. 86. HPV molecular detection and Update
    Dr Sanjay Negi
    13/04/2024, 10:25
  18. 96. Normal / Abnormal Vulval findings
    Dr Archana Mishra
    13/04/2024, 10:25
  19. 112. Video Demonstration: Normal & Abnormal Colposcolpy
    Dr Nisha Singh
    13/04/2024, 10:30
  20. 87. Immunohistochemistry for Cervical pathology
    Dr Sonali Nayak
    13/04/2024, 10:40
  21. 173. Video demonstration LSIL
    13/04/2024, 10:40
  22. 98. Treatment options for Vulva/ Vagina Lesions- Non neoplastic
    Dr Namrata . (AIIMS Raipur)
    13/04/2024, 10:45
  23. 108. Treatment protocol-Ablation: With Video Demonstration of Thermal Ablation and Cryo Therapy
    Dr Kavitha Dhanasekaran (ICMR)
    13/04/2024, 10:50
  24. 164. Technique of LBC
    Dr Mousmi Agrawal
    13/04/2024, 10:55
  25. 99. Treatment options for Vulva/ Vagina Lesions- Neoplastic.
    Dr Bhagyalaxmi Nayak
    13/04/2024, 11:05
  26. 89. Microscopy station- Cytology slides
    13/04/2024, 11:10

    Demonstration of LBC (cytology lab D block first floor)

    • Dr. Mousmi Agrawal
    • Mr. Manohar

    Cytology slides (microscopy station) seminar room deptt of pathology

    • Dr P Aruna
    • Dr Ankita Simon
    Go to contribution page
  27. 174. Video demonstration HSIL
    13/04/2024, 11:15
  28. 100. Question & Answer
    13/04/2024, 11:25
  29. 109. Treatment protocol - Excision : Video Demonstration LLETZ, NETZ, Conization
    Dr Pinnaka Vamsi (HBCHRC Visakhapatnam)
    13/04/2024, 11:25
  30. 101. Three ring Vulvoscopy, Colposcopy of Vagina, - VAIN/VIN, - Vulval biopsy, - Treatments
    Dr Bhagyalaxmi Nayak, Dr Chandrashekhar ., Dr Helen Keimei, Dr Priya Ganeshkumar, Dr Sushil Kumar Giri, Dr Vinita Singh
    13/04/2024, 11:35
  31. 110. Treatment protocol: Surgery - Choosing the correct case of invasive lesions for Surgery
    Dr Rupinder Sekhon
    13/04/2024, 11:50
  32. 176. Video demonstration: Micro Invasive
    Dr Leela Digumarti
    13/04/2024, 12:10
  33. 175. Video demonstration: Conization
    Dr Sarita Sham Sundar
    13/04/2024, 12:20
  34. 111. Question & Answer
    13/04/2024, 12:40
  35. 102. Post Test.
    13/04/2024, 12:45
  36. 113. Post Test
    13/04/2024, 12:50
  37. 90. Workshop 3 - Post Test
    13/04/2024, 12:50
  38. 129. New Paradigms in Cervical pathology and Colposcopy
    Dr Usha Saraiya
    13/04/2024, 14:00
  39. 115. Debate - For Self Sampling Against Physician collected sample for HPV
    Dr Latha Balasubramani
    13/04/2024, 14:40
  40. 178. Debate - For Physician collected sample for HPV Against Self Sampling
    Dr Helen Keimei
    13/04/2024, 14:46
  41. 116. Debate - Screening and Treatment protocol For Resource based Against Uniform
    Dr Jyoti Jaiswal
    13/04/2024, 14:55
  42. 179. Debate - Screening and Treatment protocol For Uniform Against Resource based
    Anju Singh
    13/04/2024, 15:01
  43. 117. Debate - HPV Vaccination 9-14 Yrs For One Dose Against Two Doses
    Dr Nisha Singh
    13/04/2024, 15:10
  44. 180. Debate - HPV Vaccination 9-14 Yrs For Two Doses Against One Dose
    Dr Rimpi Singla
    13/04/2024, 15:16
  45. 114. Debate - For Primary HPV Screening Against VIA for screening
    Dr Seema Singhal
    13/04/2024, 15:25
  46. 177. Debate - For VIA for screening Against Primary HPV Screening
    Dr Pushpalatha . (AIIMS Bhopal)
    13/04/2024, 15:31
  47. 139. Medicolegal issues in screening and vaccination
    Dr M.C. Patel, Dr Tripti Nagaria, Dr Meena Armo, Dr Pinnaka Vamsi, Dr Sarita Sahu, Dr Shalini Jain, Dr Avinashi Kujur, Dr Jagriti Kiran Nagar, Sushma Verma, Dr Tabassum Dalla, Dr PHEBE WALLACE Masih, Dr Mamta Jindal
    13/04/2024, 15:45
    Panel Discussion
    Panel Discussion
    • Moderator: Dr. M.C Patel
    • Expert: Dr Tripti Nagaria
    • Expert: Dr. Pinnaka Vamsi
    • Panellists: Listed as speakers below
    Go to contribution page
  48. 118. Inauguration
    13/04/2024, 17:00
  49. 119. GBM of ISCCP
    13/04/2024, 18:00
  50. 120. Cultural presentation
    13/04/2024, 19:00
  51. 121. Gala Dinner
    13/04/2024, 20:00
  52. 187. Free Paper and Poster Presentation
    14/04/2024, 09:00

    Judges:
    - Dr. Priya Ganeshkumar
    - Dr. Amrit Gupta
    - Dr. Sarita Shamsundar
    - Dr. Anju Singh

    Go to contribution page
  53. 122. Introduction
    Dr Asha Jain (CPRS)
    14/04/2024, 09:00
  54. 123. Experience with Screening in India
    Dr Sarita Sham Sundar
    14/04/2024, 09:10
  55. 124. Most effective screening protocol in India -What is new in screening
    Dr Arpan Chaturmohta
    14/04/2024, 09:25
  56. 125. Safety & efficacy of vaccines
    Dr Sarita Agrawal
    14/04/2024, 09:40
  57. 126. Experience with vaccines
    Dr Anju Rani
    14/04/2024, 09:55
  58. 128. Suggestions and strategy to fill the gaps in Elimination of Cervical Cancer
    Dr Asha Jain, Dr Monika Pathak, Dr Leela Digumarti, Dr Rimpi Singla, Dr Priya Ganeshkumar, Dr Jyothi GS, Dr Bharati Abhyankar, Kavitha Dhanasekaran (ICMR), Dr Nisha Singh, Dr Bhagyalaxmi Nayak, Dr Sushil Kumar Giri, Dr Sumedha Sircar, Dr Chandrashekhar .
    14/04/2024, 10:10
    Panel Discussion
    Panel Discussion
    • Moderator: Dr Asha Jain
    • Moderator: Dr. Monika Pathak
    • Panelists: Listed as speakers below
    Go to contribution page
  59. 127. Keynote: Role of AI and Apps in achieving WHO global targets of 90:70:90
    Dr Sankaranarayan R
    14/04/2024, 11:00
  60. 143. Keynote: Primary HPV Screening for Cervical Cancer
    Dr Neerja Bhatla
    14/04/2024, 11:20
  61. 144. Keynote: Way to achieve SDG Goals for Cervical Cancer elimination by 2030, and the available HPV tests for Screening
    Dr Elsa Díaz (Secretary IFCPC)
    14/04/2024, 11:40
  62. 145. Keynote Address
    Dr P.C. Mahapatra
    14/04/2024, 12:00
  63. 130. QUIZ
    Dr Sarita Rajbhar, Dr Sushma Verma, Dr Vinita Singh
    14/04/2024, 12:20
  64. 132. Bullets - Postpartum Vaccination?
    Dr Jyothi GS
    14/04/2024, 14:00
  65. 133. Bullets - Vaccination beyond 26 y?
    Dr Bharati Abhyankar
    14/04/2024, 14:15
  66. 134. Bullets - Screening before/after vaccination?
    Dr Shalini Jain
    14/04/2024, 14:30
  67. 136. Bullets - When to start/ stop screening?
    Dr Pushpawati Thakur PUSHPA
    14/04/2024, 14:45
  68. 137. Bullets - Obstetric complications after Treatment for CIN
    Dr Mala Shrivastava
    14/04/2024, 15:00
  69. 138. Bullets - Speculum examination- Mandatory?
    Dr Shubhangi Mundhada
    14/04/2024, 15:15
  70. 140. Counselling for HPV positives
    Dr Leela Digumarti
    14/04/2024, 15:30
  71. 141. Screening & Vaccination of HIV Positives
    Dr Sweta Balani
    14/04/2024, 15:45
  72. 165. ISCCP Journal
    Dr Sarita Shamsundar
    14/04/2024, 16:00
    Lecture
  73. 166. ISCCP Training
    Dr Mamta Dagar
    14/04/2024, 16:10
    Lecture
  74. 147. Purpose of public forum
    Dr Asha Jain
    14/04/2024, 16:30
  75. 149. Etiology
    Dr Priya Ganeshkumar
    14/04/2024, 16:35
  76. 148. WHO Goal
    Dr Sarita Agrawal
    14/04/2024, 16:40
  77. 150. Screening mothers and promoting vaccination of daughters
    Dr Anjali Pal (AIIMS Raipur)
    14/04/2024, 16:45
  78. 151. Treatment of Pre-cancer
    Dr Pushpawati Thakur PUSHPA
    14/04/2024, 16:50
  79. 152. Role of other Specialties in achieving SDG goals
    Dr Rakesh Gupta (IMA)
    14/04/2024, 16:55
  80. 153. Pediatrician Vaccination of daughters and promoting screening of their mothers
    Dr K.P. Sarabhai
    14/04/2024, 17:00
  81. 154. How to implement screening and Vaccination in all
    Dr Vikas Agrawal
    14/04/2024, 17:05
  82. 156. Role of media to increase vaccination & screening
    14/04/2024, 17:10
  83. 157. Q&A
    14/04/2024, 17:15
  84. 142. Prize distribution & valedictory
    14/04/2024, 18:00
  85. 170. AN UNUSUAL PRESENTATION OF GESTATIONAL TROPHOBLASTIC NEOPLASIA: A CASE REPORT
    RAVISHA AGGARWAL (JUNIOR RESIDENT)
    Poster

    Abstract:
    Background: Gestational trophoblastic disease (GTD) refers to a group of tumors defined by abnormal trophoblastic proliferation.The non molar or malignant forms of GTD are called gestational trophoblastic neoplasia with an incidence rate of <1% among all tumors and include invasive mole, choriocarcinoma, placental site trophoblastic tumor and epithelioid trophoblastic tumor.(1) Any...

    Go to contribution page
  86. 155. Barriers for implementation in Screening and vaccination
  87. 163. Cervical cysts - Nabothian or Pre-Invasive? - Lobular endocervical glandular hyperplasia (LEGH) in a premenopausal woman
    Akshi Garg (Department of Obstetrics and Gynecology, PGIMER Chandigarh)
    Poster

    Lobular endocervical glandular hyperplasia (LEGH) is an uncommon benign glandular proliferation that frequently affects premenopausal women. LEGH is associated with Peutz–Jeghers syndrome and germinal mutations in STK11 gene. Although it usually presents as an incidental finding, well demarcated multicystic masses with watery vaginal discharge rarely occur. Microscopically, LEGH shows a...

    Go to contribution page
  88. 186. COMPARISON OF PAP SMEAR AND VISUAL INSPECTION WITH ACETIC ACID FOR CERVICAL CANCER SCREENING IN LOW RESOURCE SETTINGS
    Panika Garg (JNIMS, Imphal)
    Paper

    Abstract:
    BACKGROUND- Cervical cancer is a preventable disease of significant public health concern especially in developing countries. Early detection of cervical cancer is possible with various screening tests like Pap smear, visual inspection with acetic acid -VIA and HPV sampling, but due to lack of awareness among many women, most of them have been infrequently or never been...

    Go to contribution page
  89. 185. Comparison of VIA with HPV DNA testing as a cervical cancer screening tool in outreach camps.
    Dr Asmita Panigrahy (Jawaharlal Nehru Institute of Medical Sciences ,Imphal)
    Paper

    Cervical cancer is the 4th most common cancer in females worldwide and accounted for 604,000 new cases and 342,000 global deaths in 2020. Most cases were from resource limited regions where ignorance, early age of marriage, increased parity, poor genital hygiene, poor nutritional status and smoking predisposes women to cervical cancer. India accounts for roughly one-third of all cervical...

    Go to contribution page
  90. 158. Diagnostic Accuracy of Triple Test versus Colposcopy for the Detection of Precursors of Cervical Carcinoma
    Dr Harshad Bagde (MS obgy)
    Paper

    Background: The gold standard for identifying cervical cancer precursors is a biopsy taken by colposcopy, followed by histological examination. In high-resource settings, this approach is highly successful. Thus, in low-resource settings, the World Health Organization recommends using other tests, including Lugol's iodine or visual inspection with 3-5 percent acetic acid (VIA), for the...

    Go to contribution page
  91. 181. Home Based screening of cervical cancer - A pilot study in a urban slum in Cuttack.
    Anwesa Pal (Resident AHPGIC), Prof. BHAGYALAXMI NAYAK (HOD GYNE -ONCO AHPGIC CUTTACK)
    Paper

    Background: Persistent infection with high-risk human papillomavirus (HPV) causes virtually all cervical cancers. Two high-risk types, HPV 16 and HPV 18 cause 70% of cervical cancers worldwide. Nearly all sexually active people will become infected with HPV at some point in their lives. Most HPV infections go away on their own within a year or two as our immune system controls the...

    Go to contribution page
  92. 162. Laser conization : Possibilities and limitations
    Dr Neha Kumar (HBCHRC Visakhapatnam)
    Poster

    Background: Cervical intraepithelial lesion (CIN) can be treated with surgical excision or ablative methods. Laser can be used both ways i.e to excise the tissue as well do ablative vaporization. Laser conization combines the best of two approaches, however currently we have limited literature for its use in the Indian setting.

    Aim and Objectives
    To evaluate the...

    Go to contribution page
  93. 160. PREVALENCE OF PREINVASIVE LESIONS OF CERVIX IN HUMAN PAPILLOMA VIRUS (HPV) POSITIVE WOMEN AT A TERTIARY CARE INSTITUTION - A RETROSPECTIVE STUDY
    Dr Pushpawati Thakur (Additional Professor)
    Paper

    INTRODUCTION: Cervical cancer is the most common gynecological cancer worldwide. In resource limited countries it is the 3rd most common cause of cancer mortality. High Risk HPV infection is the most important risk factor in pathogenesis of cervical cancers. Robust screening with primary HPV test and co testing has decreased the incidence of cervical cancer by allowing precursor lesions to...

    Go to contribution page
  94. 172. Question & Answer
  95. 161. Reid Colposcopic Index Versus Swede Score For Cervical Cancer Screening- A Comparative Prospective Study
    Dr Akriti Singh, Dr Pragya Jain Pragya
    Paper

    Abstract
    Introduction: Cervical cancer is the second most common malignancy among women in India. The pap smear being the most commonly used screening tool has low sensitivity. Colposcopy determines the location, size and extent of abnormal cervical lesions. Guided biopsy can be taken. The Colposcopic scoring systems are Reid’s colposcopic index (RCI) and Swede score with later also...

    Go to contribution page
  96. 169. Risk factors of residual disease after cold knife conization and optimizing cone size to predict positive surgical margins: A single centre experience
    Dr Archana Mishra (Professor, Department of Obstetrics and Gynaecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi)
    Poster

    Introduction: Goal of treatment of precancerous lesion is to remove the cervical lesion with adequate surgical margins as well as whole transformation zone. Positive margins after cold knife conization are a risk factor for residual disease and failure of treatment.

    Methodology: It is an ongoing prospective study done in our institute since January 2022 including all the patients undergoing...

    Go to contribution page
  97. 168. SOCIAL DETERMINANTS AFFECTING INCIDENCE OF CERVICAL CANCER.
    DR MANZER SHAIKH (AMWI, CYTOLOGY CLINIC, AMS NEOLIFE CLINIC)
    Paper

    Cervical cancer is second commonest cancer in India. In November 2017, WHO called for elimination of cervical cancer. The incidence and mortality of cervical cancer shows a global disparity. In developed countries it is 5-6/100000 whereas in developing countries it is still 20-25/100000. The incidence and mortality are both related to human development index in a particular location. It is...

    Go to contribution page
  98. 167. THE ROLE OF ARTIFICIAL INTELLIGENCE IN CERVICAL CANCER SCREENING: A SYSTEMATIC REVIEW AND META ANALYSIS
    Dr PATEL MIT ALPESHKUMAR OBGYN (2nd YEAR PG RESIDENT)
    Paper

    TITLE : THE ROLE OF ARTIFICIAL INTELLIGENCE IN CERVICAL CANCER SCREENING: A SYSTEMATIC REVIEW AND META ANALYSIS
    NAME OF AUTHORS : Dr. PATEL MIT ALPESHKUMAR ( 2nd year PG Result), Dr. PROF MADHU JAIN ( Proffesor and Head), Dr. VIBHA MISHRA (Assistant professor)
    BACKGROUND: This study examines the impact of cervical cancer on underdeveloped nations and underscores the urgent need for rapid,...

    Go to contribution page
  99. 182. Title: Opportunistic cervical cancer screening in tertiary cancer centre of Eastern India.
    ANIRBAN TALUKDER
    Paper

    BACKGROUND: Cervical cancer is one of the most common cancers among Indian women ,but it is preventable by adequate screening and proper vaccination
    OBJECTIVE:To determine the correlation of visual inspection acetic acid (VIA), liquid based cytology (LBC) and human papilloma virus (HPV) testing in opportunistic screening population and also to find out their diagnostic accuracy....

    Go to contribution page
  100. 159. Topical Imiquimod treatment versus large loop excision of the transformation zone (LLETZ), an open-label randomized controlled trial in newly diagnosed Cervical Intraepithelial neoplasia.
    Dr Adhithya Raj P K (All India Institute Of medical Sciences Raiput)
    Paper

    Introduction: Cervical cancer is a significant global health concern, particularly in regions lacking comprehensive screening and treatment programs. Cervical Intraepithelial Neoplasia (CIN) is a precursor to cervical cancer, often caused by Human Papillomavirus (HPV) infection. This study compared the efficacy and safety of topical Imiquimod therapy with the standard Large Loop Excision of...

    Go to contribution page
  101. 183. Uterine Leiomyosarcoma: Masquerading as Advanced Carcinoma Cervix
    Dr Tuba Tahseen
    Poster

    INTRODUCTION:
    Uterine leiomyosarcoma is a rare uterine malignancy that arises from the smooth muscle of the uterine wall, making up 2% to 5% of all uterine malignancies. It often presents with abnormal vaginal bleeding (56%), palpable pelvic mass (54%), and/or pelvic pain (22%). The majority of patients (60%) are diagnosed with early-stage disease. However, in a rare case it may mimic...

    Go to contribution page
  102. 171. “Cervical Tuberculosis in a young reproductive age female mimicking Cervical cancer: A rare differential diagnosis”
    Pooja Deshmukh (AIIMS Raipur)
    Poster

    This is a rare case of a 27 year old young female with complaints of postcoital bleeding associated with abdominal pain since 1 year. On per speculum examination, a large irregular friable growth was seen which used to bleed on touch. A provisional diagnosis of carcinoma cervix was made, but the cervical biopsy revealed granulomatous inflammation with central necrosis, consistent with the...

    Go to contribution page